Full View

Population pharmacokinetics of teicoplanin in preterm and term neonates: is it time for a new dosing regimen?

A Kontou, K Sarafidis, O Begou, HG Gika… - Antimicrobial Agents …, 2020 - Am Soc Microbiol
Our objective was to develop a population pharmacokinetic (PK) model in order to evaluate
the currently recommended dosing regimen in term and preterm neonates. By using an …
被引用次数：9 相关文章
[HTML] nih.gov

[HTML][HTML] Population Pharmacokinetics of Teicoplanin in Preterm and Term Neonates: Is It Time for a New Dosing Regimen?

A Kontou, K Sarafidis, O Begou, HG Gika… - Antimicrobial Agents …, 2020 - ncbi.nlm.nih.gov
Our objective was to develop a population pharmacokinetic (PK) model in order to evaluate
the currently recommended dosing regimen in term and preterm neonates. By using an …

Population Pharmacokinetics of Teicoplanin in Preterm and Term Neonates: Is It Time for a New Dosing Regimen?

A Kontou, K Sarafidis, O Begou… - Antimicrobial …, 2020 - research.manchester.ac.uk
Our objective was to develop a population pharmacokinetic (PK) model in order to evaluate
the currently recommended dosing regimen in term and preterm neonates. By using an …

Population Pharmacokinetics of Teicoplanin in Preterm and Term Neonates: Is It Time for a New Dosing Regimen?

A Kontou, K Sarafidis, O Begou, HG Gika… - Antimicrobial Agents …, 2020 - europepmc.org
Our objective was to develop a population pharmacokinetic (PK) model in order to evaluate
the currently recommended dosing regimen in term and preterm neonates. By using an …

Population pharmacokinetics of teicoplanin in preterm and term neonates: is it time for a new dosing regimen?

A Kontou, K Sarafidis, O Begou, HG Gika, A Tsiligiannis… - 2020 - cabidigitallibrary.org
Our objective was to develop a population pharmacokinetic (PK) model in order to evaluate
the currently recommended dosing regimen in term and preterm neonates. By using an …

Population Pharmacokinetics of Teicoplanin in Preterm and Term Neonates: Is It Time for a New Dosing Regimen?

A Kontou, K Sarafidis, O Begou, HG Gika… - Antimicrobial Agents …, 2020 - cir.nii.ac.jp
抄録< jats: p> Our objective was to develop a population pharmacokinetic (PK) model in
order to evaluate the currently recommended dosing regimen in term and preterm neonates …

Population Pharmacokinetics of Teicoplanin in Preterm and Term Neonates: Is It Time for a New Dosing Regimen?

A Kontou, K Sarafidis, O Begou… - Antimicrobial …, 2020 - pubmed.ncbi.nlm.nih.gov
Our objective was to develop a population pharmacokinetic (PK) model in order to evaluate
the currently recommended dosing regimen in term and preterm neonates. By using an …